AfatinibDiarrhoea and paronychia: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1658卷 / 1期

关键词：

D O I：

10.1007/s40278-017-32221-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：24 / 24

相关论文

共 50 条

[41] ErlotinibAlopecia, folliculitis and paronychia: case report
Reactions Weekly, 2010, 1289 (1) : 18 - 18
[42] AfatinibSkin toxicity and paronychia: case report
Reactions Weekly, 2019, 1770 (1) : 23 - 23
[43] AfatinibGrade 2-3 skin rash and paronychia : case report
Reactions Weekly, 2022, 1914 (1) : 23 - 23
[44] AfatinibDiarrhoea, oral mucositis and rashes on the face and trunk: case report
Reactions Weekly, 2019, 1779 (1) : 18 - 18
[45] AfatinibAcne, paronychia and diarrhoea: case report
Reactions Weekly, 2017, 1642 (1) : 22 - 22
[46] SorafenibCutaneous bullae and paronychia: case report
Reactions Weekly, 2018, 1725 (1) : 269 - 269
[47] AfatinibDiarrhoea, oral ulcers and skin adverse events: case report
Reactions Weekly, 2019, 1735 (1) : 19 - 19
[48] DiclofenacNSAID colopathy: two case reports: 2 case reports
Reactions Weekly, 2013, 1480 (1) : 17 - 17
[49] AfatinibRash, paronychia and treatment failure: case report
Reactions Weekly, 2022, 1887 (1) : 29 - 29
[50] NatalizumabFirst reports of sarcoidosis: 2 case reports
Reactions Weekly, 2012, 1388 (1) : 23 - 23

← 1 2 3 4 5 →